Monday July 6th, 2020 4:25PM

Gilead's $2,340 price for coronavirus drug draws criticism

By The Associated Press
Related Articles
  Contact Editor

The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries.

Gilead Sciences announced the price Monday for remdesivir, and said the price would be $3,120 for patients with private insurance. The amount that patients pay out of pocket depends on insurance, income and other factors.

“We’re in uncharted territory with pricing a new medicine, a novel medicine, in a pandemic,” Gilead’s chief executive, Dan O’Day, told The Associated Press.

“We believe that we had to really deviate from the normal circumstances” and price the drug to ensure wide access rather than based solely on value to patients, he said.

However, the price was swiftly criticized; a consumer group called it “an outrage” because of the amount taxpayers invested toward the drug's development.

The treatment courses that the company has donated to the U.S. and other countries will run out in about a week, and the prices will apply to the drug after that, O'Day said.

In the U.S., federal health officials have allocated the limited supply to states, but that agreement with Gilead will end after September. They said Monday that the government has secured more than 500,000 additional courses that Gilead will produce starting in July to supply to hospitals through September, and stressed that that does not mean the government actually was acquiring that much, just ensuring the availability.

“We should have sufficient supply ... but we have to make sure it’s in the right place at the right time," O’Day said

In 127 poor or middle-income countries, Gilead is allowing generic makers to supply the drug; two countries are doing that for around $600 per treatment course.

Remdesivir’s price has been highly anticipated since it became the first medicine to show benefit in the pandemic, which has killed more than half a million people globally in six months.

The drug, given through an IV, interferes with the coronavirus’s ability to copy its genetic material. In a U.S. government-led study, remdesivir shortened recovery time by 31% — 11 days on average versus 15 days for those given just usual care. It had not improved survival according to preliminary results after two weeks of followup; results after four weeks are expected soon.

The Institute for Clinical and Economic Review, a nonprofit group that analyzes drug prices, said remdesivir would be cost-effective in a range of $4,580 to $5,080 if it saved lives. But recent news that a cheap steroid called dexamethasone improves survival means remdesivir should be priced between $2,520 and $2,800, the group said.

“This is a high price for a drug that has not been shown to reduce mortality,” Dr. Steven Nissen of the Cleveland Clinic said in an email. “Given the serious nature of the pandemic, I would prefer that the government take over production and distribute the drug for free. It was developed using significant taxpayer funding.”

Peter Maybarduk, a lawyer at the consumer group Public Citizen, called the price “an outrage.”

“Remdesivir should be in the public domain” because the drug received at least $70 million in public funding toward its development, he said.

“The price puts to rest any notion that drug companies will ‘do the right thing’ because it is a pandemic,” Dr. Peter Bach, a health policy expert at Memorial Sloan Kettering Cancer Center in New York said in an email. “The price might have been fine if the company had demonstrated that the treatment saved lives. It didn’t.”

While it may be a sticker shock for many, “from the health system perspective, if remdesivir can shorten duration of hospitalization by four days, then the medicine provides a reasonable value,” Dr. David Boulware, an infectious disease specialist at the University of Minnesota, said in an email.

O’Day said that shortening hospitalization saves about $12,000 per patient. Gilead says it will have spent $1 billion on developing and making the drug by the end of this year. Gilead shares rose 64 cents to $75.22 in late-morning trading.

The drug has emergency use authorization in the U.S. and Gilead has applied for full approval.

Jefferies pharmaceuticals analyst Michael Yee wrote to investors that Gilead’s price was a bit above what stock brokers were expecting. He said that at that price, analysts expect Gilead to make $525 million on remdesivir sales this year and $2.1 billion next year.

___

Marilynn Marchione can be followed on Twitter: @MMarchioneAP

___

AP Business Writer Linda A. Johnson contributed to this report.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

  • Associated Categories: U.S. News, Associated Press (AP), AP National News, Top U.S. News short headlines, AP Health, AP Business, AP Business - Industries, AP Business - Health Care
© Copyright 2020 AccessWDUN.com
All rights reserved. This material may not be published, broadcast, rewritten, or redistributed without permission.
Gilead's $2,340 price for coronavirus drug draws criticism
The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries
8:57AM ( 13 minutes ago )
Couple draw guns at crowd heading to St. Louis mayor's home
A white couple pointed guns at protesters in St. Louis, Missouri, as the group marched toward the mayor’s home, demanding her resignation after she publicly read the names and addresses of several residents who supported defunding the police department
8:37AM ( 32 minutes ago )
Mississippi surrenders Confederate symbol from state flag
Mississippi is retiring the last state flag in the U.S. that includes the Confederate battle emblem
8:07AM ( 1 hour ago )
U.S. News
The Latest: Tokyo sees virus infections rise in nightclubs
Japan’s capital city of Tokyo has reported 58 new cases of coronavirus and a top government official said the trend doesn’t look good
9:01AM ( 9 minutes ago )
Patriots owner's prostitution case heads to appellate court
Prosecutors charging New England Patriots owner Robert Kraft with buying sex from massage parlor prostitutes are trying to save their case
8:54AM ( 15 minutes ago )
Myanmar military warning of action causes thousands to flee
Thousands of people in an area of western Myanmar where there have been clashes between the government and ethnic rebels have been fleeing from their villages after an evacuation order from officials
8:26AM ( 44 minutes ago )
Associated Press (AP)
Trump denies briefing about reported bounties on US troops
The White House plans to brief select members of Congress after news reports citing U.S. intelligence that a Russian military intelligence unit secretly offered bounties to Taliban-linked militants for killing American troops in Afghanistan
7:26AM ( 1 hour ago )
Militants attack Karachi stock exchange, killing at least 3
Militants have attacked the stock exchange in the Pakistani city of Karachi, killing at least two security guards and a policeman
7:10AM ( 2 hours ago )
Testing stepped up as number of new coronavirus cases surges
Governments are stepping up testing and warily considering their next moves as the number of newly confirmed coronavirus cases surges in many countries
6:28AM ( 2 hours ago )
AP National News
World markets subdued as virus fears cloud recovery outlook
World stock markets are subdued as rising virus cases lead some U.S. states to backtrack on pandemic reopening plans
7:17AM ( 1 hour ago )
The Latest: Greece eases more coronavirus restrictions
Movie theaters, casinos and children’s summer camps reopened in Greece on Monday, while concerts, conferences, commercial fairs and artistic events can once again be held, in the latest phase of the country’s easing of lockdown measures
7:16AM ( 1 hour ago )
EU, UK keen to step up the pace as trade talks resume
European Union and U.K. negotiators on Monday resumed in-person talks on a post-Brexit trade deal, with both sides keen to pick up the pace to try to clinch an agreement by the end of the year
6:40AM ( 2 hours ago )
AP Business
Apple, AT&T, Jack Daniel's: Fed issues details on bond buys
The Federal Reserve has released a list of roughly 750 companies, including Apple, Walmart and ExxonMobil, whose corporate bonds it will purchase in the coming months in an effort to keep borrowing costs low and smooth the flow of credit
9:45PM ( 11 hours ago )
Fracking pioneer Chesapeake files for bankruptcy protection
Chesapeake Energy, a shale drilling pioneer which was once one of the largest natural gas producers in the U.S., has filed for bankruptcy protection
7:04PM ( 14 hours ago )
The Latest: Russia reports 6,791 new cases in past day
Russia has recorded 6,791 new cases in the past day
9:41AM ( 23 hours ago )
AP Business - Industries
Honolulu to reopen campgrounds for first time in 3 months
The city of Honolulu has announced that campgrounds will reopen for the first time in three months with limited permits to ensure social distancing amid the coronavirus pandemic
8:28PM ( 1 day ago )
Lower-income California areas more likely to be hit by virus
Data show hundreds of new infections in densely populated neighborhoods that are more likely home to low-income residents in one California county
8:00PM ( 1 day ago )
Arkansas reports 570 more coronavirus cases, 10 more deaths
Arkansas on Saturday reported 570 more cases of the coronavirus and 10 more deaths
7:53PM ( 1 day ago )
AP Business - Health Care
Couple draw guns at crowd heading to St. Louis mayor's home
A white couple pointed guns at protesters in St. Louis, Missouri, as the group marched toward the mayor’s home, demanding her resignation after she publicly read the names and addresses of several residents who supported defunding the police department
8:37AM ( 32 minutes ago )
Mississippi surrenders Confederate symbol from state flag
Mississippi is retiring the last state flag in the U.S. that includes the Confederate battle emblem
8:07AM ( 1 hour ago )
UK judge warns Assange on US extradition hearing attendance
A British judge says Julian Assange must attend his next court hearing unless he can provide medical evidence to support his absence
7:58AM ( 1 hour ago )
Gilead prices coronavirus drug at $2,340 for rich countries
The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries
7:24AM ( 1 hour ago )
California's alleged Golden State Killer set to plead guilty
A 74-year-old former police officer is tentatively set to plead guilty Monday to being the elusive Golden State Killer
11:53PM ( 9 hours ago )